Valuation (67%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -77.82 | 95.09 |
| PEG Ratio (TTM) | 0.46 | -1.70 |
| P/S Ratio (TTM) | 1.16 | 1.30 |
| P/B Ratio (TTM) | 1.06 | 1.91 |
| P/FCF Ratio (TTM) | 67.13 | -1.21 |
| Price to 5YR AVG Earnings Ratio | 8.84 | 22.82 |
| Price to 5YR AVG FCF Ratio | 6.89 | 8.48 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -1.05% | 2.82% |
| ROE (TTM) | -1.34% | 5.04% |
| Net Profit Margin (TTM) | -1.54% | 1.62% |
| ROIC 5YR AVG | 26.47% | 19.78% |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -14.27% | 237.42% | 115.57% |
| Revenue | -3.50% | 45.09% | 18.81% |
| Net Income | -13.26% | 297.98% | 150.50% |
| Cash Flow | 244.15% | 405.50% | 220.49% |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.82 | 2.68 |
| Quick Ratio (TTM) | 1.17 | 1.82 |
| D/E Ratio (TTM) | 0.07 | 1.03 |
| Interest Coverage (TTM) | -2.96 | 11.32 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 3.58 | 3.25 |
| LTL to 5YR AVG FCF | 0.21 | 6.90 |
| Shares Outstanding Growth 5YR AVG | 5.14% | 2.06% |